INTRODUCTION
Sustained interest in many laboratories in the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) stems from the fact that it is neurotoxic to primates and certain other species, producing Parkinsonian symptoms in humans. The toxic form is the oxidation product, 1-methyl-4-phenylpyridinium (MPP+), produced by the action of monoamine oxidase B in brain and accumulated in dopaminergic neurons by the dopamine re-uptake system. Cell death probably ensues from ATP depletion, initiated by the inhibition of mitochondrial respiration on NAD+-linked substrates [1] [2] [3] . Support for this ' mitochondrial' hypothesis has come from the demonstration [4] that the pyridinium oxidation products of all neurotoxic MPTP analogues inhibit mitochondrial respiration as well as NADH oxidation in inverted mitochondrial membranes. Further evidence for the mitochondrial hypothesis has come from the protective effect of barbiturates against the toxicity of MPP+ to dopaminergic neurons in culture [5] , from mitochondrial abnormalities in MPTP-treated monkeys, and from reports of Complex I deficiency in idiopathic Parkinsonian patients [6, 7] .
It was nevertheless desirable to obtain more direct evidence that the reaction site of MPP+ is as postulated, i.e. on the highpotential end of NADH dehydrogenase, where ubiquinone (Q) reacts. The localization was based on e.p.r. experiments [8] analogous to earlier work [9] , showing that rotenone, piericidin A and barbiturates block NADH oxidase between NADH dehydrogenase and Q. It was also known that piericidin A, rotenone and barbiturates bind at the same site in mitochondria in a competitive manner [10] . None of these inhibitors bind covalently to the inhibitor site, although the non-covalent bonds are tight enough in the case of piericidin A and rotenone that they do not dissociate on dilution, in contrast with MPP+ [8] .
The recent availability of 4'-alkyl-substituted MPP+ analogues with IC50 values (concentrations causing 50% inhibition) for NADH oxidation in the micromolar range [11, 12] , which nevertheless dissociate readily and can be removed by centrifugation of membrane preparations, resulting in regeneration of NADH oxidase activity, provided the opportunity to examine whether these tightly bound analogues protect NADH dehydrogenase from inhibition by the binding of piericidin A and rotenone. We have briefly reported [13] 
EXPERIMENTAL
Electron transport particles (ETP) from bovine heart mitochondria were prepared according to Crane et al. [14] , and NADH oxidase activity was measured spectrophotometrically [15] . MPP+ and its 4'-substituted analogues, as well as 4'-pentyl-4-phenylpyridine, were synthesized as described elsewhere [11] .
[14C]Piericidin A (specific radioactivity 0.8 Ci/mol) was the sample used in our previous work [10] and was shown to be chemically and radiochemically pure by co-chromatography on t.l.c. with an authentic synthetic sample kindly provided by Dr. N. Takahashi (University of Tokyo, Tokyo, Japan).
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Abbreviations used: ETP, electron transport particles (inverted inner membrane preparation); MPTP, 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPP+, 1-methyl-4-phenylpyridinium species; TPB-, tetraphenylboron anion; IC50, concentration resulting in half-maximal inhibition.
1 1 To whom correspondence should be addressed, at the Department of Veterans Affairs Medical Center. Incubations with piericidin A were carried out in a final volume of 1 ml containing 2-3 mg of ETP protein in 0.25 Msucrose/0.05 M-potassium phosphate, pH 7.4, containing 200 (w/v) BSA. The latter was included to minimize spurious piericidin A binding [10] . After the addition of MPP+ analogues at the concentrations specified in the Figure and Table legends,  plus 10 ,tM-tetraphenylboron (TPB-) to enhance the rate of binding of the pyridinium to the inhibitory site by ion-pairing [16, 17] , the samples were incubated for 5 min at 30°C, then labelled or unlabelled piericidin A was added in a small volume of ethanol followed by NADH to give a concentration of 1 mm. The samples were further incubated for 10 min at 30°C, chilled in ice and centrifuged for 30min at 1446000g. The pellets were resuspended in 1 ml of sucrose/phosphate/BSA containing the MPP+ analogues and TPB-at the same concentrations as in the initial incubation, held at 0°C for 15 min and centrifuged as before. In experiments using [14C]piericidin A, washing by resuspension and centrifugation were repeated a second time. After final resuspension, the NADH oxidase activity was determined in a portion and the rest of the particles were collected by centrifugation and the bound 14C was measured. The purpose of washing of the particles first in a solution containing the MPP+ analogue was to prevent rebinding of spuriously bound piericidin A which dissociates under these conditions. Piericidin A bound at the specific site responsible for inhibition does not dissociate on dilution. The second centrifugation and resuspension removes the MPP+ analogues which dissociate readily.
RESULTS AND DISCUSSION
We have reported [11, 12] Table 1 . First, washing by centrifugation and resuspension in the absence of the 4'-analogue was performed three times, so as to remove most of the highly hydrophobic heptyl and t-butyl analogues and thus minimize residual inhibition by these compounds. Secondly, advantage was taken of the observation that, as in the case of rotenone [13] , protection of the enzyme from piericidin A by MPP+ analogues is concentration-dependent. Therefore the ratio of MPP+ analogue to piericidin A was lowered in order to demonstrate the relative effectiveness of different compounds. Fig. 1 shows that at a concentration of 32 times the IC50 value, 4'-pentyl-MPP+ was the most effective, was kept low so as to minimize its own inhibitory effect. Even so, it lowered the residual activity from the 700 of the original control observed with piericidin A alone to virtually zero. Fig. also shows the correlation between the activity protected and the decrease in binding of ['4C]piericidin to the specific site. In the absence of MPP+ analogues, 1.7 mol of piericidin A was specifically bound per mol of NADH dehydrogenase. The enzyme concentration was calculated from the NADH ferricyanide activity, in comparison with the turnover number of the highly purified enzyme [18] , as in previous work [19] . The data in Fig.  1 show that the 4'-methyl, 4'-propyl and 4'-pentyl analogues prevented the binding of piericidin A and its inhibitory effect to nearly the same extent. In the case of the two highly hydrophobic MPP+ derivatives, limited prevention of binding seemed to exceed protection from inactivation somewhat, but this was due entirely to residual inhibition by these two analogues. When corrected for their inhibitory effect, the two parameters measured were nearly equal. The IC50 values for the inhibitory effect of MPP+ analogues on NADH dehydrogenase summarized above do not show a quantitative relationship with their potential protective effect against piericidin A. This is to be expected, of course, from the fact that the former is a kinetic parameter and the latter measures an equilibrium. However, the tightly bound 4'-heptyl analogue (IC50 = 6 #M in the presence of TPB-) is virtually ineffective as a protective agent. Even more striking is the fact that under the same experimental conditions with both analogues present at 50 times the IC50, 4'-pentyl-MPP+ prevented the inhibition by piericidin A extensively, whereas 4'-pentyl-4-phenylpyridine had no effect (Fig. 2) . It seems that, perhaps Vol. 273 Although other interpretations cannot be excluded, the simplest conclusion is that MPP+ and its analogues bind at or near the 'rotenone site' on NADH dehydrogenase, i.e. the region where piericidin A and barbiturates bind and block re-oxidation of the enzyme [9, 10] . 
